LZAGF News and Press, Lonza Group AG

2026-05-08 14:51:19 ET Lonza Group AG (LZAGY) Q1 2026 Earnings Call May 8, 2026 8:00 AM EDT Company Participants Philippe Deecke - Chief Financial Officer Conference Call Participants James Quigley - Goldman Sachs Group, Inc., Research Division Zain Ebr...

2026-04-01 06:03:33 ET A year after our last update, we are back to comment on Lonza Group AG (LZAGY) (LZAGF). This was very good timing (we buy rated Lonza just after liberation day, with a follow-up note on the company's ability to navigate tariff turmoil due to its extensive indu...

2026-03-09 05:05:55 ET Lonza Group AG (LZAGY) Discusses Divestment of Capsules and Health Ingredients Business and Focus on CDMO Transformation March 9, 2026 3:00 AM EDT... Read the full article on Seeking Alpha For further details see: Lonza Group AG (LZAGY) Discusses Dives...

2026-01-29 12:17:19 ET More and more it feels like companies across industries have bought into the idea that it is often best to specialize in whatever it is they do best and outsource as much of what remains as is practical. In the case of pharmaceutical and biotech companies (“bio...

2026-01-28 13:52:24 ET Lonza Group AG (LZAGY) Q4 2025 Earnings Call January 28, 2026 8:00 AM EST Company Participants Wolfgang Wienand - Chief Executive Officer Philippe Deecke - Chief Financial Officer David Carter ... Read the full article on Seeking Al...

2026-01-13 16:25:58 ET Lonza Group AG (LZAGY) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 1:30 PM EST... Read the full article on Seeking Alpha For further details see: Lonza Group AG (LZAGY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transc...

2025-10-23 14:17:28 ET Lonza Group AG (LZAGY) Q3 2025 Earnings Call October 23, 2025 8:00 AM EDT Company Participants Philippe Deecke - Chief Financial Officer Conference Call Participants Zain Ebrahim - JPMorgan Chase & Co, Research Division Charle...

2025-10-09 07:25:54 ET Investment Thesis I grant Lonza Group ( OTCPK:LZAGY ) a hold rating. I am of the opinion that it is too early to change my rating. On the one hand, the company exhibits robust growth, achieving a 16.98% increase in its revenues in in the first half of 2025...

2025-09-26 04:59:57 ET More on drugmakers AstraZeneca: Oncology Breakthroughs And Farxiga Surge Excite Investors Takeda: Excellent Pipeline Kaizen - 6 Drugs, $20 Billion Annually GSK plc (GSK) plc Presents at Bank of America Global Healthcare Conference 2025 Transcri...

2025-07-23 12:03:41 ET Lonza Group AG (LZAGY) Q2 2025 Earnings Conference Call July 23, 2025 08:00 AM ET Company Participants Philippe Deecke - Chief Financial Officer Wolfgang Wienand - Chief Executive Officer Conference Call Participants Charles Pitman ...